340.38 USD
-9.62 (-2.75%)
At close: Jan 30, 2026
340.38 USD
0 (0%)
After Hours: 1/30/2026, 8:11:42 PM
ChartMill assigns a Buy % Consensus number of 83% to ONC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 347.71. This target is 2.15% above the current price.
- ONC was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ONC.
- In the previous month the buy percentage consensus was at a similar level.
- ONC was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-18 | Barclays | Initiate | Overweight |
| 2025-08-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-27 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-06-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-24 | TD Securities | Reiterate | Buy -> Buy |
| 2025-04-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-16 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-07 | RBC Capital | Initiate | Outperform |
| 2025-02-28 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-28 | Macquarie | Maintains | Outperform -> Outperform |
BEONE MEDICINES LTD-ADR / ONC FAQ
What is the average price target for BEONE MEDICINES LTD-ADR (ONC) stock?
16 analysts have analysed ONC and the average price target is 347.71 USD. This implies a price increase of 2.15% is expected in the next year compared to the current price of 340.38.
What is the consensus rating for ONC stock?
The consensus rating for BEONE MEDICINES LTD-ADR (ONC) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.